Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy-Reference-Cited by-同舟云学术

Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy

Published:2017-03-01 Issue:3 Volume:12 Page:e0171460
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Horibe Ryota,Hirohashi Yoshihiko,Asano Takuya,Mariya Tasuku,Suzuki Takeshi,Takaya Akari,Saijo Hiroshi,Shionoya Yosuke,Kubo Terufumi,Nakatsugawa Munehide,Kanaseki Takayuki,Tsukahara Tomohide,Watanabe Kazue,Atsuyama Eri,Toji Shingo,Hirano Hiroshi,Hasegawa Tadashi,Takahashi Hiroki,Sato Noriyuki,Torigoe Toshihiko

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Cancer statistics, 2015;RL Siegel;CA: a cancer journal for clinicians,2015

2. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer;M Shapiro;Chest,2013

3. The Evolution of Therapies in Non-Small Cell Lung Cancer;V Boolell;Cancers,2015

4. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions;JE Visvader;Nat Rev Cancer,2008

5. Cancer stem cell-directed therapies: recent data from the laboratory and clinic;CY Park;Molecular therapy: the journal of the American Society of Gene Therapy,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy;Cancer Science;2023-06-21

2. A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors;International Journal of Molecular Sciences;2023-03-22

3. BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial‐mesenchymal transition and hepatic stellate cells;Molecular Carcinogenesis;2023-03-17

4. The function of brother of the regulator of imprinted sites in cancer development;Cancer Gene Therapy;2022-11-14

5. Nanodrug delivery systems and cancer stem cells: From delivery carriers to treatment;Colloids and Surfaces B: Biointerfaces;2022-09